Khloris Biosciences

Khloris Biosciences, founded in the San Francisco Bay Area, is a private biotechnology company with a mission to revolutionize medical treatment and prevention of cancer and other diseases. The company focuses on harnessing the immunotherapeutic potential of induced pluripotent stem cells (iPSCs) for drug discovery, vaccine development, and cell therapies. Their core vision is to pioneer cancer vaccination and define the future of cancer and cardiovascular medicine.

Notable figures affiliated with Khloris Biosciences include leading scientists and industry experts in the field of stem cell research and immunotherapy. The company has attracted significant interest from investors due to its innovative approach and potential for high-impact treatments. Key achievements include the development of proprietary platforms leveraging iPSCs, positioning Khloris Biosciences as a transformative player in the biotech industry. Their work promises to significantly impact cancer treatment and preventative medicine, aiming for a world without cancer.